Papers by William B. White
Page 2 · newest first
- A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertensionJournal of Hypertension · 2018
- Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER StudyAmerican Journal of Nephrology · 2018
- High‐sensitivity C ‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE ( Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care ) trialDiabetes Obesity and Metabolism · 2017
- Impact of the Norepinephrine Prodrug Droxidopa on the QTc Interval in Healthy IndividualsClinical Pharmacology in Drug Development · 2017
- Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertensionJournal of Clinical Hypertension · 2017
- Timed mobility: description of measurement, performance, and dimensionality among older adultsDisability and Rehabilitation · 2017
- Utility of ambulatory blood pressure monitoring for the management of hypertensionCurrent Opinion in Cardiology · 2017
- Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)Circulation · 2017
- Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trialDiabetes Obesity and Metabolism · 2017
- Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he EXAMINE trialDiabetes Obesity and Metabolism · 2017
- Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic HypotensionThe American Journal of Cardiology · 2017
- Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotideJournal of Hypertension · 2016
- Cardiovascular safety of therapies for type 2 diabetesExpert Opinion on Drug Safety · 2016
- Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotensionJournal of the American Society of Hypertension · 2016
- Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotensionJournal of the American Society of Hypertension · 2016
- Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor AlogliptinHypertension · 2016
- Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialDiabetes Care · 2016
- Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversionEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2016
- Cardiovascular Effects of Incretin-Based TherapiesAnnual Review of Medicine · 2016
- Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood PressureHypertension Journal · 2016
- Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older personsJournal of Cerebral Blood Flow & Metabolism · 2015
- Treatment of Hypertension in Patients With Coronary Artery DiseaseCirculation · 2015
- Treatment of Hypertension in Patients With Coronary Artery DiseaseHypertension · 2015
- Exposure to Racial Discrimination and Ambulatory Blood Pressure in Women with Type 2 DiabetesStress and Health · 2015
- Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research ConsortiumAmerican Heart Journal · 2015
- Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes MellitusHypertension · 2014
- Efficacy of azilsartan medoxomil with chlorthalidone in hypertensionExpert Review of Cardiovascular Therapy · 2014
- Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertensionBlood Pressure Monitoring · 2014
- Safety and Tolerability of Edivoxetine for Long-Term Treatment of Major Depressive Disorder in Adult PatientsOpen Journal of Psychiatry · 2014
- Clinical Practice Guidelines for the Management of Hypertension in the CommunityJournal of Clinical Hypertension · 2013
- Clinical Practice Guidelines for the Management of Hypertension in the CommunityENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2013
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 DiabetesNew England Journal of Medicine · 2013
- Rapid Buildup of Brain White Matter Hyperintensities Over 4 Years Linked to Ambulatory Blood Pressure, Mobility, Cognition, and Depression in Old PersonsThe Journals of Gerontology Series A · 2013
- Rationale for Establishing a Mechanism to Increase Reimbursement to Hypertension SpecialistsJournal of Clinical Hypertension · 2013
- Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramiprilJournal of Human Hypertension · 2013
- Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitusDiabetes Obesity and Metabolism · 2013
- Mobility impairment is associated with reduced microstructural integrity of the inferior and superior cerebellar peduncles in elderly with no clinical signs of cerebellar dysfunctionNeuroImage Clinical · 2013
- Azilsartan Medoxomil Plus Chlorthalidone Reduces Blood Pressure More Effectively Than Olmesartan Plus Hydrochlorothiazide in Stage 2 Systolic HypertensionHypertension · 2012
- Safety of Mineralocorticoid Receptor Antagonists in Patients Receiving HemodialysisAnnals of Pharmacotherapy · 2012
- Blood Pressure–Lowering Efficacy of the Fixed‐Dose Combination of Azilsartan Medoxomil and Chlorthalidone: A Factorial StudyJournal of Clinical Hypertension · 2012
- Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate‐to‐Severe HypertensionInternational Journal of Hypertension · 2012
- Azilsartan Medoxomil: A New Angiotensin II Receptor Antagonist for Treatment of HypertensionAnnals of Pharmacotherapy · 2011
- Average Daily Blood Pressure, Not Office Blood Pressure, Is Associated With Progression of Cerebrovascular Disease and Cognitive Decline in Older PeopleCirculation · 2011
- Evaluation of the Migraine Treatment Sumatriptan/Naproxen Sodium on Blood Pressure Following Long-Term AdministrationJournal of Clinical Hypertension · 2011
- Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary HypertensionCirculation · 2011
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional TreatmentJAMA · 2011
- Impact of NSAIDs on cardiovascular risk and hypertensionItalian Journal of Medicine · 2011
- Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure MonitoringJournal of Clinical Hypertension · 2011
- A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronismENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2011
- Safety and Tolerability of the Direct Renin Inhibitor Aliskiren in Combination With Angiotensin Receptor Blockers and Thiazide Diuretics: A Pooled Analysis of Clinical Experience of 12,942 PatientsJournal of Clinical Hypertension · 2011